Condon J R, Nassim J R, Dent C E, Hilb A, Stainthorpe E M
Postgrad Med J. 1978 Apr;54(630):249-52. doi: 10.1136/pgmj.54.630.249.
Patients with steroid-induced, juvenile and senile osteoporosis were studied using balance techniques. The changes in calciun and phosphorus balance associated with glucocorticoid therapy were corrected with vitamin D and bendrofluazide given in combination. No hypercalcaemia occurred in osteoporotic patients who continued to receive glucocorticoids. Calcium and phosphorus balance was also improved in the osteoporotic subjects not receiving steroids, but these patients became hypercalcaemic during treatment. It is suggested that vitamin D, bendrofluazide and steroids antagonize the actions of one another on the renal tubule, gut and bone and in this way prevent the increased calciuria which occurs with glucocorticoid therapy. Since the increased calciuria and negative calcium balance induced by glucocorticoids is considered to be the result of excessive bone resorption, an adequate dose of bendrofluazide and vitamin D in combination might prevent the development of, or even reverse, steroid-induced osteoporosis.
采用平衡技术对患有类固醇诱导性、青少年和老年性骨质疏松症的患者进行了研究。联合使用维生素D和苄氟噻嗪纠正了与糖皮质激素治疗相关的钙和磷平衡变化。继续接受糖皮质激素治疗的骨质疏松症患者未出现高钙血症。未接受类固醇治疗的骨质疏松症患者的钙和磷平衡也有所改善,但这些患者在治疗期间出现了高钙血症。提示维生素D、苄氟噻嗪和类固醇在肾小管、肠道和骨骼上相互拮抗作用,从而防止糖皮质激素治疗时出现的尿钙增加。由于糖皮质激素引起的尿钙增加和负钙平衡被认为是骨吸收过多的结果,适当剂量的苄氟噻嗪和维生素D联合使用可能预防类固醇诱导性骨质疏松症的发生,甚至使其逆转。